Dublin, March 27, 2026 (GLOBE NEWSWIRE) — The “Clinical Nutrition for Cancer Care Market Report 2026” has been added to ResearchAndMarkets.com’s offering.
The clinical nutrition for cancer care market has experienced substantial growth, with the market size set to increase from $5.16 billion in 2025 to $5.42 billion in 2026, representing a compound annual growth rate (CAGR) of 5.1%. This upward trend is driven by a rise in cancer cases, expansion of oncology treatment centers, heightened awareness of nutrition in cancer treatment, and the availability of specialized oncology nutrition products.
Looking ahead, the market continues to project steady growth, anticipated to reach $6.5 billion by 2030 with a CAGR of 4.6%. Future growth will be fueled by a focus on personalized oncology care, increased demand for high-protein and immune-supporting nutrition, expansion of outpatient cancer treatment models, and advances in digital nutrition monitoring tools. Key trends include the adoption of personalized nutrition plans, increased use of specialized enteral and parenteral formulations, and expansion of home-based clinical nutrition support.
The prevalence of cancer is a major factor driving market expansion. The World Health Organization projects approximately 35 million new cancer cases worldwide by 2050, a 77% increase from 2022 levels. This rise accentuates the need for tailored dietary management as part of cancer treatment, aimed at improving patients’ clinical outcomes and treatment tolerance.
In the realm of personalized cancer care, companies are increasingly utilizing data-driven methodologies and advanced genomic profiling. This includes the analysis of patients’ genetic makeup to enhance diagnosis, treatment planning, and prognosis. For instance, Aster DM Healthcare introduced Precision Oncology, a platform that leverages genomic analysis to deliver personalized cancer care solutions.
Strategic collaborations further bolster market dynamics. In January 2024, Danone S.A. partnered with Resilience to introduce an integrated nutrition and oncology module into Resilience’s digital platform, enhancing support for cancer-related malnutrition.
Leading companies in this sector include Abbott Nutrition, Baxter International Inc., B Braun Melsungen AG, Danone Nutricia, and others. North America leads the market in regions, while other regions covered in the market report include Asia-Pacific, Western Europe, and more.
Market challenges include tariffs impacting the cost of imported raw ingredients and nutrients, influencing product pricing and procurement budgets. However, this challenge is also prompting local sourcing and regional production capabilities.
Report Scope
The report addresses pivotal questions about market dynamics, its economic implications, demographic ties, and similar market comparisons. It forecasts the forces, including technological advancements, regulatory changes, and shifting consumer trends, that will shape the future of clinical nutrition for cancer care.
Key Market Insights:
Detail market characteristics, highlighting major product offerings and groundbreaking innovation trends.Supply chain analysis outlines the value chain, listing key raw materials and competitors.Updated trends focus on digitization, sustainability, and AI innovation, offering strategies for competitive advantages.Assessment of the regulatory and investment environment details regulatory frameworks and investment trends driving growth.Historic and forecasted market size figures offer a comprehensive understanding of the market’s trajectory.Analyzes external influences like AI advances, geopolitical tensions, and inflationary pressures on market forecasts.TAM analysis estimates potential growth, offering strategic insights.Market attractiveness scoring quantifies growth potential and competitive standing.Detailed segmentations and regional breakdowns offer granular geographic market insights.Competitive landscape details company standings, market shares, and recent pivotal financial transactions.
Segmentation
Markets explored include types such as Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas, across various cancer types and age groups. Companies featured range from Abbott Nutrition to Ajinomoto Co Inc.
Global Coverage
Countries covered include Australia, Brazil, China, and more, across regions like Asia-Pacific, Western Europe, and North America. This extensive geographic analysis reflects crucial realignments in global supply and manufacturing chains.
Key Attributes
Report AttributeDetailsNo. of Pages250Forecast Period2026-2030Estimated Market Value (USD) in 2026$5.42 BillionForecasted Market Value (USD) by 2030$6.5 BillionCompound Annual Growth Rate4.6%Regions CoveredGlobal
The companies featured in this Clinical Nutrition for Cancer Care market report include:
Abbott NutritionBaxter International Inc.B Braun Melsungen AGNestle Health Science S ADanone NutriciaHormel Health LabsEvonik Industries AGOtsuka Holdings Co LtdKoninklijke DSM N VGlanbia plcMeiji Holdings Company LtdVictus Inc.Global Health Products Inc.Fresenius Kabi AGPerrigo Company plcArla Foods Ingredients Group P SKerry Group plcLonza Group AGAjinomoto Co Inc.Yakult Honsha Co LtdRousselot BVTate Lyle plcADM Human NutritionVitaflo International LtdSmartfish ASMedtrition Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4h2x29
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Clinical Nutrition for Cancer Care Market
